does bcbsil cover glp-1 for weight loss Blue Cross Blue Shield to stop covering popular weight-loss drugs Medicaid Coverage of and Spending
Description
R.TreichelA
Hypothalamic GPCR signaling pathways in cardiometabolic control
Drug Saf
GLP-1 RA treatment has been reported to increase irisin levels in patients with obesity and T2D
Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Digestive side effects are common, particularly when starting treatment
